Find a Provider

Specialty:: Dermatology
Dermatology, Mohs-Micrographic Surgery
Department Affiliation:: Medicine
Hospital Affiliation:: Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica
State License:: G76728
Phone:: 310-825-6911
Health Plans:: Accepted Plans

About Me: Jenny Kim, MD is a Professor of Clinical Medicine at the David Geffen School of Medicine at UCLA and Chief of Dermatology at the Greater Los Angeles Healthcare System Veterans Affairs. Dr. Kim received her MD and PhD in Immunology from UCLA and also completed her Dermatology residency and Mohs Micrographic Surgery fellowship there. She has been a UCLA faculty member since 2000 where she serves as referral source for patients requiring rejuvenation for aging skin and also for patients with skin cancers. In her laboratory at the Center for Health Sciences, Dr. Kim studies the immune response in skin and is funded by the National Institutes of Health. Dr. Kim is studying innate immunity in skin diseases in collaboration with the UCLA Center for Human Nutrition.
Links: uclahealth.org/dermatology
clinicalnutrition.ucla.edu
uclahealth.org/weight-management

Primary Office: Dermatology - Westwood
Primary Address: 200 UCLA Medical Plaza
Suite 465
Los Angeles, California 90095
: Get Directions
: View Map
Phone: 310-825-6911
Fax: 310-794-7005
Secondary Office: Dermatology - Westwood
Secondary Address: 100 UCLA Medical Plaza
Suite 216
Los Angeles, California 90095
: Get Directions
: View Map
Phone: 310-206-7546
Fax: 310-794-7005

Medical Board Certifications: Dermatology, American Board of Dermatology, 1999
Fellowship: Dermatology Surgery/Mohs Micrographic Surgery, UCLA School of Medicine, 1999-2000
Fellowship 2: Microbiology/Immunology, UCLA School of Medicine, 1993-1995
Residency: Dermatology, UCLA School of Medicine, 1995-1999
Residency 2: Surgery, Harbor - UCLA Medical Center, 1992-1993
Internship: Surgery, Harbor - UCLA Medical Center, 1991-1992
Degree: UCLA School of Medicine, MD, 1991

Interests

Aesthetic Dermatology (BOTOX, Fillers, and Chemical Peels)
Botox
Chemical Peels
Chemical Peel
A chemical peel uses a chemical solution to improve the skin's appearance by removing the damaged outer layers. It can reduce or remove fine lines under the eyes and around the mouth.
Learn more >
Collagen Injection
Cosmetic
Dermabrasion/Microdermabrasion
Dermabrasion and Dermaplaning
Dermabrasion involves a surgeon using a high speed rotating brush to remove the top layer of skin. This is done to remove fine wrinkles or minimize scars. The size and depth of the scars, as well as the degree of wrinkling, determine the appropriate level of skin that will be surgically sloughed.
Learn more >
Dermatology Surgery
Laser Surgery for Lesions and Skin Conditions
There are many different types of lesions and skin conditions that can be treated with laser surgery. These include birthmarks, which are skin abnormalities present at birth. Your healthcare provider will decide if you are a candidate for the particular surgery.
Learn more >
Hair Removal With Laser
Laser
Lipoinjection
Liposuction
Liposuction
Liposuction removes excess body fat through a suctioning process. It is not a substitute for weight loss, but it does change the body's shape and contour.
Learn more >
MOH's Micrographic Surgery
Scar Revision
Scar Revision
A scar revision is a procedure done on a scar to alter the appearance of the scar. The revision may improve the cosmetic appearance of the scar or restore function to a part of the body that may have been restricted by the scar. It is important to remember that scars cannot be completely removed.
Learn more >
Skin Cancer
Melanoma: Introduction
Melanoma is a serious type of skin cancer. It starts in skin cells called melanocytes. Melanocytes are what give skin its color. There are 3 main types of skin cancer. Basal cell carcinoma and squamous cell carcinoma are more common. Melanoma is a much less common, but melanoma is more likely to spread to other parts of the body.
Learn more >
Spider Veins
Tattoo Removal
Laser Surgery for Lesions and Skin Conditions
There are many different types of lesions and skin conditions that can be treated with laser surgery. These include birthmarks, which are skin abnormalities present at birth. Your healthcare provider will decide if you are a candidate for the particular surgery.
Learn more >

Research Interests

Skin Immunity
Photoaging
Acne

Publications

Ohmen JD, Hanifin JM, Nickoloff BJ, Rea TH, Wyzykowski R, Kim J, Jullien D, McHugh T, Nassif AS, Chan SC, Modlin RL. Overexpression of IL-10 in Atopic Dermatitis. Journal of Immunology, 154:1956-1963, 1995.
Kim J, Modlin RL, Moy RL, Dubinett S, McHugh T, Nickoloff BJ, Uyemura K. IL-10 Production in Cutaneous Basal and Squamous Cell Carcinomas: A Mechanism for Evading the Local T Cell Immune Response. Journal of Immunology, 155: 2240-2247, 1995.
Kim J, Sette A, Rodda S, Southwood S, Mehra V, Oliveros J, Sieling PA, Rea TH, Bloom BR, Modlin RL. Determinants of T-cell Reactivity to the Mycobacterium leprae GroES Homolog. Journal of Immunology, 159:335-343, 1997.
Kim J, Beddingfield FC, Lask GP. Non-ablative Facial Resurfacing. Operative Techniques in Oculoplastic, Orbital, and Reconstructive Surgery, 3:55-57, 2000.
Yamauchi PS, Bleharski JR, Uyemura K, Kim J, Sieling PA, Miller A, Brightbill H, Schlienger K, Rea TH, Modlin RL. A role for CD40-CD40 Ligand interactions in the Generation of Type 1 Cytokine Responses in Human Leprosy. Journal of Immunology, 165:1506-1512, 2000.
Kim J, Uyemura K, Van Dyke MK, Legaspi A, Presky DH, Rea TH, Shuai K, Modlin RL. A role for IL-12 receptor expression and signal transduction in host defense in leprosy. Journal of Immunology, 167:779-786, 2001.
Grimes PE, Bhawan J, Kim J, Chiu M, Lask G. Laser resurfacing-induced hypopigmentation: histologic alterations and repigmentation with topical photochemotherapy. Dermatologic Surgery, 27:515-520, 2001.
Kim J, Ochoa MT, Krutzik S, Takeuchi O, Uematsu S, Legaspi A, Brightbill H, Holland D, Cunliffe WJ, Akira S, Sieling PA, Godowski PJ, Modlin RL. Activation of Inflammatory Cytokine Responses in Acne Occurs through Toll-like Receptor 2. Journal of Immunology, 169:1535-1541, 2002.
Arora T, Liu B, He H, Kim J, Murphy TL, Murphy KM, Modlin RL, Shuai K. Inhibition of Stat-4-mediated Gene Activation by PIASx. Journal of Biological Chemistry, 278:21327-21330, 2003.
Liu P, Krutzik S, Kim J, Modlin R. Cutting edge: All-trans retinoic acid downregulates Toll-like receptor-2 expression and function. Journal of Immunology, 174:2467-2470, 2005.
Miller LS, Sorensen OE, Liu PT, Jalian HR, Eshtiaghpour D, Behmanesh BE, Chung W, Stamer TD, Kim J, Sieling PA, Ganz T, Modlin RL. TGFa regulates Toll-like receptor expression and function on epidermal keratinocytes. Journal of Immunology, 174:6137-6143, 2005.
McInturff J, Wang S-J, Machleidt T, Lin R, Oren A, Hertz C, Krutzik S, Hart S, Zeh K, Anderson D, Gallo R, Modlin RL, Kim J. Granulysin-derived Peptides Demonstrate Antimicrobial and Antiinflammatory Activity against Propionibacterium acnes. J Invest Dermatol 125:256-263, 2005.
Ko CJ, Kim J, Phan J, Binder SW. Bcl-2-positive epidermal dendritic cells in inverted follicular keratoses but not squamous cell carcinomans or Seborrheic keratoses. J Cutaneous Pathology 33:498-501, 2006.
Liu PT, Phan J, Tang D, Kanchanapoomi M, Hall B, Krutzik SR, Kim J. CD209+ macrophages mediate host defense against Propionibacterium acnes. Journal of Immunology 180:4919-23, 2008.
Greco, J, Soriano S, Lask GP, Kim J. Combination Treatment with Broadband Light and Erbium-Doped Yttrium Aluminium Garnet MicroLaser Peel for Photoaged Skin: Case Report of Four Patients. Dermatol Surg 34:1603-8, 2008.
Jalian HR, Liu PT, Kanchanapoomi M, Legaspi A, Modlin RL, Kim J. All-trans retinoic acid shifts Propionibacterium acnes induced matrix degradation expression profile toward matrix preservation in human monocytes. Journal of Investigative Dermatology 128:2777-82, 2008.
Custis T, Beynet D, Carranza D, Greco J, Lask GP, Kim J. Comparison of treatment of melomental fold rhytides with cross-linked hyaluronic acid combined with onabotulinumtoxina and cross-linked hyaluronic acid alone. Dermatol Surg 2010 36:1852-8, 2010.
Cho JS, Zussman J, Donegan NP, Ramos RI, Garcia NC, Uslan DZ, Iwakura Y, Simon SI, Cheung AL, Modlin RL, Kim J, Miller LS. Noninvasive in vivo imaging to evaluate immune responses and antimicrobial therapy against Staphylococcus aureus and USA300 MRSA skin infections. J Invest Dermatol 131:907-15, 2011.
Ahdout J, Kotlerman J, Elashoff D, Kim J, Chiu MW. Modifiable lifestyle factors associated with metabolic syndrome in patients with psoriasis. Clin Exp Dermatol 37 (5):477-83, 2012.
Chesnut C, Kim J. Is there truly no benefit with sunscreen use and basal cell carcinoma? A critical review of the literature and the application of new sunscreen labeling rules to real-world sunscreen practices. J Skin Cancer Volume 2012, 2012. PMCID: PMC3357551
Marinelli L, Fitz-Gibbon S, Hayes C, Bowman C, Inkeles M, Loncaric A, Russell D, Jacobs-Sera D, Cokus S, Pellegrini M, Kim J, Miller J, Hatfull G, Modlin RL. Propionbacterium acnes bacteriophages display limited genetic diversity and broad killing activity against bacterial skin isolates. MBio 3(5): e00279-12 2012. PMCID: PMC3448167
Friedman AJ, Phan J, Tang D, Blecher K, Oren A, Liu P, Modlin RL, Kim J. Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogens. J Invest Dermatol 133(5):1231-9, 2013. PMCID: PMC3631294
Fitz-Gibbon S, Tomida S, Chiu BH, Nguyen L, Du C, Liu M, Elashoff D, Erfe MC, Loncaric A, Kim J, Modlin RL, Miller JF, Sodergren E, Craft N, Weinstock GM, Li HY. Propionibacterium acnes strain populations in the skin microbiome associated with acne. J Invest Dermatol Jan 2013. (Epub ahead of print).
Champer J, Patel J, Fernando N, Salehi E, Wong V, Kim J. Chitosan against cutaneous pathogens. AMB Express 2013 Jul 6;3(1):3. (Epub ahead of print).
Agak G, Qin M, Nobe J, Kim M-H, Krutzik SR, Tristan GR, Elashoff D, Garban H, Kim J. Propionibacterium acnes-induced an IL-17 response in acne vulgaris that is regulated by vitamin A and vitamin D (accepted to J Invest Dermatol, April 2013).
Qin M, Pirouz A, Kim MH, Krutzik S, Garban H, Kim J. Propionibacterium acnes induces IL-1ß secretion via the NLRP3 inflammasome in human monocytes (accepted to J Invest Dermatol, May 2013).

Awards

Association of American Medical Colleges, Mid-Career Women Faculty Professional Development Seminar Selected Participant 2012
UCLA Dean's recognition for Science Faculty Research 2011
Selected as the12th Medical-Pharmaceutical Research Scholar, Dong Sung Pharmaceutical Foundation 2009
American Dermatologic Association, elected member 2008-ADDED
First Prize for Scientific Poster Presentation at the American Academy of Dermatology 65th Annual Meeting 2007
American Academy of Dermatology Leadership Circle for Volunteerism, Member Making a Difference 2006
American Acne and Rosacea Society Found Director 2005
The William J. Cunliffe Prize, EADV Congress 2004
SID/Galderma Acne Research Award 2003
American Academy of Dermatology Awards for Young Investigators In Dermatology 2001
Nelson Paul Anderson Lecture Award, Pacific Dermatologic Association 1997
Lazar Grant Scholarship at UCLA School of Medicine 1987
Golden Key National Honor Society 1986
University of California at Berkeley, Honor Society 1982-1986
Jean Liberty Scholarship at UC Berkeley 1982

Jenny J. Kim, MD, PhD click here to update your profile

Back to search

Find a Provider

Find a Provider

Chemical Peel

Dermabrasion and Dermaplaning

Laser Surgery for Lesions and Skin Conditions

Liposuction

Scar Revision

Melanoma: Introduction

Laser Surgery for Lesions and Skin Conditions